ScholarGate
어시스턴트

방법 비교

선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.

EORTC QLQ-BR23: 유방암 환자의 삶의 질×EORTC QLQ-LC13: 폐암에서의 삶의 질×
분야종양학종양학
계열Process / pipelineProcess / pipeline
기원 연도19961994
창시자Sprangers, M. A., et al. (EORTC Quality of Life Group)Bergman, B., et al. (EORTC Quality of Life Group)
유형Self-report questionnaireSelf-report questionnaire
원전Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗
별칭QLQ-BR23QLQ-LC13
관련55
요약The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.
ScholarGate데이터셋
  1. v1
  2. 2 출처
  3. PUBLISHED
  1. v1
  2. 2 출처
  3. PUBLISHED

검색으로 이동 슬라이드 다운로드

ScholarGate방법 비교: EORTC QLQ-BR23 · EORTC QLQ-LC13. 2026-06-19에 다음에서 검색함: https://scholargate.app/ko/compare